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Introduction 
Methods 
• We reviewed the medical records of 9,748 
patients hospitalized with ADHF at all 11 
medical centers in central Massachusetts 
during 1995, 2000, 2002, and 2004 
• Information on patient’s demographic, clinical, 
and treatment characteristics was analyzed 
using standard methods, including 
multivariable regression 
• Mortality was assessed by reviewing statewide 
death certificates, the Social Security Death 
Index, and hospital medical records at 
participating medical centers  
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Conclusions 
 
In-hospital Mortality 
30-Day Post-Discharge 
Mortality 
20% 15% 
• Heart failure (HF) is a highly prevalent, morbid, 
and costly disease with a poor long-term 
prognosis 
• HF affects more than 6.6 million Americans and 
causes more than 275,000 deaths annually 
• Evidence-based therapies utilized over the past 
2 decades hold the promise of improved 
outcomes, yet few contemporary studies have 
examined survival trends in patients with acute 
decompensated heart failure (ADHF) 
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• Patients with ADHF were increasingly elderly and 
had multiple comorbidities associated with poor 
outcomes 
• Both short and long-term survival for these 
patients improved significantly between 1995 
and 2004, but their long-term prognosis remains 
poor, as fewer than 1 in 3 patients hospitalized 
with ADHF in 2004 survived more than 5 years 
• While there has been encouraging progress in 
the treatment and prognosis of patients 
hospitalized with ADHF, additional opportunity 
remains to improve the in-hospital and post-
discharge management of patients with this 
common and debilitating clinical syndrome  
 
 
n=9,748           *Similar trends for inpatient medications 
Objectives 
• The primary objective of this population-based 
study was to describe trends in short and long-
term survival in patients hospitalized with ADHF   
• A secondary objective was to examine patient 
characteristics associated with decreased long-
term survival 
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Total Population 1995 Cohort 2004 Cohort 
(n=9,748) (n=1,949) (n=2,469) 
 Age (mean, years) 76.2 75.7 76.2 
 Age >85 years 25.7  21.4  28.4  
 Male (%) 43.9 42.9 46.9  
 Caucasian (%) 93.8 96.8 92.3 
 Incident event (%) 29 26.1 36.4 
 Systolic blood pressure (mmHg) 142.7  145.9  140.5  
 Diastolic blood pressure (mmHg) 74.7  79.1  72.5  
 Cholesterol (mg/dL) 162.5 175.6 150.4 
 Creatinine (mg/dL) 1.64 1.57 1.77 
 Blood Urea Nitrogen (mg/dl) 34.4 33.3 35.5 
 Glucose (mg/dL) 158.5 165.6 152.5 
 Ejection fraction (%) 45.4 41.7 46.9 
 LOS (days) 6.1 7.4 6.1 
 
 Medical History (%)  
  
 Anemia 24.6 21.9 26.7 
 Coronary Heart Disease 56 57 55.7 
 Chronic Lung Disease 35.9 35.5 35.7 
 Diabetes 39 39.7 39.3 
 Hypertension 68.7 62.3 72.8 
 Peripheral Vascular Disease 19.7 20.2 21 
 Renal Failure/Disease 25.9 21.5 31.4 
 Stroke 13.2 14.3 11.5 
 
 Symptoms (%) 
  
 Angina/Chest Pain 31.2 31.2 29.9 
 Dyspnea/Shortness of Breath 93.4 96.5 92.2 
 Swelling 70.3 63.8 72.7 
 Nausea/Vomiting 16 14.2 17.1 
 Orthopnea 35.4 29.2 38.4 
 Weakness 25.1 24.9 23.8 
 Weight Gain 8 6.8 8.9 
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5 Year Survival 
1995        19% 
2004        28% 
n=9,748 
Long Term Survival Improving, but 
Still Poor 
HF Patients are Increasingly Elderly 
and Debilitated 
 
Over ¼ of patients admitted with HF are >85 years old 
Control of cholesterol, BP, and glucose has improved over time 
 
Factor 
 
All Patients 
(Hazard Ratio) 
Incident Cases 
(Hazard Ratio) 
 Age (yrs) 
          65-74 1.45 1.67 
          75-84 1.91 2.36 
          >85 2.72 3.48 
 Male 1.06 1.23 
 White race 1.38 1.59 
 Incident case 0.71 -- 
  
 Medical History 
 
 Anemia 1.15 1.26 
 Coronary heart disease 1.02 1.02 
 Chronic obstructive pulmonary disease 1.27 1.52 
 Diabetes 1.1 1.1 
 Hypertension 0.9 0.88 
 Peripheral vascular disease 1.08 1.11 
 Renal disease 1.14 1.13 
 Stroke 1.2 1.26 
 Serum glucose (mg/dl) 
          140-199 1 0.99 
          >200 1 1.14 
 Systolic BP (mmHg) 
          100-159 0.81 0.99 
          >160 0.7 0.86 
 Diastolic BP (mmHg) 
          60-89 1.01 0.95 
          >90 0.99 1 
 Heart rate (bpm) 
         60-99 1.04 1.14 
         >100 1.11 1.12 
 Blood urea nitrogen (mg/dl) >43 1.43 1.31 
 Serum Sodium (mmol/L) <135 1.13 1.07 
Factors Associated with Post-
Discharge Mortality 
 
older age, male sex, prior HF, chronic kidney disease, COPD, diabetes, peripheral 
vascular disease, anemia and stroke were associated with poor long-term survival 
